Long-Term Results (10 Years)
摘要
Starting from 2014, sleeve gastrectomy has become the most prevalent metabolic and bariatric surgery (MBS) procedure in all IFSO chapters. Originally described as the initial step of the biliopancreatic diversion/duodenal switch (BPD/DS), due to its efficacy in inducing weight loss as a single procedure, laparoscopic vertical sleeve gastrectomy (LSG) is now the most performed bariatric surgery worldwide as a stand-alone approach. At first, this procedure was performed exclusively by laparoscopy, but nowadays, robotic platforms have made sleeve gastrectomy (RSG) more and more popular. Due to both its relative technical ease and long-term efficacy in treating obesity and its related comorbid conditions, the sleeve gastrectomy has grown in popularity among patients and surgeons. Multiple studies have analyzed the procedure efficacy and challenges over a 10-year period. Key findings indicate sustained weight reduction, significant improvement in obesity-related comorbidities, but also potential risks such as gastroesophageal reflux disease (GERD) and Barrett’s esophagus (BE) onset.